%A SONG Shu-An, PU Da-Xun, JIANG Tao, JING Qiong-You, WANG Jian-Bing %T Impact of the signal path PD-1/PD-L1 on Treg cells and tumor cells %0 Journal Article %D 2014 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2014.11.003 %P 808-810 %V 41 %N 11 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9541.shtml} %8 2014-12-03 %X Programmed death1 (PD1) and its ligand PDL1 are the major members of inhibitory costimulatory molecules and express high in a variety of tumor cells and their associated cells surface, while the proportion of regulatory T cells (Tregs) are abnormally elevated in tumor infiltrating T lymphocytes cells. PDL1 combined with PD1 and Treg help tumors evade immune clearance, weaken immune responses and induce immune tolerance. New researches find that PDL1 plays an important role in the development and function maintenance of inducible Treg (iTreg), and PDL1 signal can change initial CD4+ CD25- T cells into iTreg to play a role of immunosuppression. Research on PD1 signaling pathway can provide a new theoretical basis for the inhibition of tumor immune escape in clinical application of immunotherapy and better treatments.